Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors

Kotryna Seip; Karianne G. Fleten; Anna Barkovskaya; Vigdis Nygaard; Mads H. Haugen; Birgit Ø. Engesæter; Gunhild M. Mælandsmo; Lina Prasmickaite

doi:10.18632/oncotarget.7671

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors

By Kotryna Seip, Karianne G. Fleten, Anna Barkovskaya, Vigdis Nygaard, Mads H. Haugen, Birgit Ø. Engesæter, Gunhild M. Mælandsmo and Lina Prasmickaite

Publisher: Impact Journals, LLC

Year: 2016

DOI identifier: 10.18632/oncotarget.7671

OAI identifier:

Provided by: MUCC (Crossref)

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the
following location(s):}

http://europepmc.org/articles/... (external link)

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors

Suggested articles